Hjem › Myelodysplastiske syndromer
Kliniske studier for Myelodysplastiske syndromer rekrutterer i USA
157 studier for Myelodysplastiske syndromer rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- New York City, NY21 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Boston, MA19 studier
- Tampa, FL19 studier
- Miami, FL17 studier
- Columbus, OH14 studier
- Durham, NC14 studier
- Chicago, IL13 studier
- Atlanta, GA13 studier
- St. Louis, MO13 studier
- Cleveland, OH11 studier
- Nashville, TN11 studier
- Philadelphia, PA10 studier
- Birmingham, AL10 studier
- Los Angeles, CA10 studier
- Mountain View, CA9 studier
- Pittsburgh, PA9 studier
- Baltimore, MD9 studier
- Winston-Salem, NC9 studier
- Jacksonville, FL9 studier
- The Bronx, NY9 studier
- Portland, OR8 studier
- Buffalo, NY8 studier
- New Haven, CT8 studier
- Milwaukee, WI8 studier
- Minneapolis, MN8 studier
- Salt Lake City, UT8 studier
- Memphis, TN7 studier
- Clifton, NJ7 studier
- Cedar Rapids, IA7 studier
- Edison, NJ7 studier
- Orange, CA7 studier
- Kansas City, MO7 studier
- San Francisco, CA6 studier
- Aurora, CO6 studier
- Rochester, NY6 studier
- Queens, NY6 studier
Etter delstat
- Alabama10 studier
- Arizona9 studier
- Arkansas4 studier
- California41 studier
- Colorado8 studier
- Connecticut10 studier
- District of Columbia4 studier
- Florida31 studier
- Georgia15 studier
- Hawaii3 studier
- Idaho4 studier
- Illinois16 studier
- Indiana4 studier
- Iowa7 studier
- Kansas5 studier
- Kentucky5 studier
- Louisiana5 studier
- Maine4 studier
- Maryland23 studier
- Massachusetts21 studier
- Michigan8 studier
- Minnesota13 studier
- Mississippi3 studier
- Missouri15 studier
- Montana3 studier
- Nebraska4 studier
- Nevada3 studier
- New Hampshire5 studier
- New Jersey13 studier
- New Mexico4 studier
- New York38 studier
- North Carolina19 studier
- North Dakota4 studier
- Ohio22 studier
- Oklahoma4 studier
- Oregon10 studier
- Pennsylvania17 studier
- Rhode Island4 studier
- South Carolina7 studier
- Tennessee15 studier
- Texas44 studier
- Utah8 studier
- Vermont3 studier
- Virginia8 studier
- Washington21 studier
- West Virginia4 studier
- Wisconsin11 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
RekruttererFase 1/2
Alder 12 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06303193Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06577441Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06904066Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
RekruttererObservasjonsstudie
1 Day – 99 Years · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07683104Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06484062Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
RekruttererFase 1/2
Alder 4 til 75 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT03173937The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07285044A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruttererFase 1
Alder 12 til 78 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT03802695CHIP/CCUS Natural History Protocol
RekruttererObservasjonsstudie
Alder 18 til 99 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT04102423MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05564390A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06548230Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT03661307Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05320198Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
RekruttererFase 2
Alder 4 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT01174108Natural History Study of GATA2 Deficiency and Related Disorders
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 til 100 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT01905826A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07422480Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
RekruttererFase 1
Alder 1 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT03630991CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04375631Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04282187Collection of Tissue Samples for Cancer Research
RekruttererObservasjonsstudie
2 Months · Alle kjønn · Oppdatert 16. sep. 2026 · NCT00900198Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06904482Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT03471260Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT03683433A Study of BGB-11417 in Participants With Myeloid Malignancies
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT04771130Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.